EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Oral Pre-malignancy: An Update on Novel Therapeutic Approaches

Shorook Naara, Clara Andrews, Andrew Sikora, Michelle Williams, Mark Chambers, Jeffrey Myers, Moran Amit

Current Oncology Reports · 2024

DOI: 10.1007/s11912-024-01562-1 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Current Oncology Reports, 2024. Verfasst von Shorook Naara und 6 weiteren Autor:innen. Beteiligte Einrichtung: The Department of Head and Neck Surgery, University of Texas, MD Anderson Cancer Center, Houston, TX, USA. Hauptthemen laut MEDLINE: Mouth Neoplasms, Precancerous Conditions. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 86 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE OF REVIEW: This review aims to provide a comprehensive overview of the current advances in managing and preventing progression of oral potentially malignant disorders (OPMDs), focusing on their histological and clinicopathological features, and management. RECENT FINDINGS: Recent studies, including a multicenter cross-sectional study, have identified oral leukoplakia as the most prevalent form of OPMD, comprising over half of the cases examined. Advances in histological grading, specifically the World Health Organization's three-tier system (mild, moderate, and severe dysplasia), have significantly enhanced the accuracy of risk assessment for malignant transformation. Additionally, treatments such as surgical interventions, photodynamic therapy, and chemopreventive and molecularly targeted agents are being evaluated for their safety and efficacy as well as, immune checkpoint inhibitors being evaluated as potential preventive strategies to halt the progression of OPMDs. The management of OPMDs remains challenging due to the lack of standardized screening protocols and varied clinical management approaches. Despite this, recent advancements in diagnostic grading and therapeutic interventions provide a framework for improved treatment outcomes. Continued research into the molecular and cellular mechanisms driving development and progression of OPMDs and innovative treatment trials are essential to optimize strategies that prevent malignant progression and thereby reduce the global health burden of oral cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mouth NeoplasmsPrecancerous ConditionsHumansLeukoplakia, OralDisease Progression

Stichwörter der Autor:innen

ChemopreventionHistological GradingImmune Checkpoint InhibitorsOral Potentially Malignant Disorders (OPMDs)

Autor:innen und Institutionen

  • The Department of Head and Neck Surgery, University of Texas, MD Anderson Cancer Center, Houston, TX, USA.
  • Department of Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA.
  • The Department of Head and Neck Surgery, University of Texas, MD Anderson Cancer Center, Houston, TX, USA. moranamit@gmail.com.

Zitieren

APA

Naara, S., Andrews, C., Sikora, A., Williams, M., Chambers, M., Myers, J., & Amit, M. (2024). Oral Pre-malignancy: An Update on Novel Therapeutic Approaches. Current Oncology Reports. https://doi.org/10.1007/s11912-024-01562-1

Vancouver

Naara S, Andrews C, Sikora A, Williams M, Chambers M, Myers J, et al. Oral Pre-malignancy: An Update on Novel Therapeutic Approaches. Current Oncology Reports. 2024. doi:10.1007/s11912-024-01562-1

BibTeX
@article{Naara2024,
  author = {Naara, Shorook and Andrews, Clara and Sikora, Andrew and Williams, Michelle and Chambers, Mark and Myers, Jeffrey and Amit, Moran},
  title = {Oral Pre-malignancy: An Update on Novel Therapeutic Approaches},
  journal = {Current Oncology Reports},
  year = {2024},
  doi = {10.1007/s11912-024-01562-1}
}
Kostenlos starten →